Stryker Corporation (SYK) is a Medical - Devices company in the Healthcare sector, currently trading at $345.88. It has a SharesGrow Score of 74/100, indicating a above average investment profile with 5 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of SYK = $411.27 (+18.9% from the current price, the stock appears undervalued). Analyst consensus target is SYK = $429 (+23.9% upside).
Valuation: SYK trades at a trailing Price-to-Earnings (P/E) of 39.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 3.34.
Financials: revenue is $25.1B, +10.8%/yr average growth. Net income is $3.2B, growing at +12.4%/yr. Net profit margin is 12.9% (healthy). Gross margin is 64% (+1.2 pp trend).
Balance sheet: total debt is $14.9B against $22.4B equity (Debt-to-Equity (D/E) ratio 0.66, moderate). Current ratio is 1.89 (strong liquidity). Debt-to-assets is 31.1%. Total assets: $47.8B.
Analyst outlook: 36 / 50 analysts rate SYK as buy (72%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 32/100 (Fail), Growth 80/100 (Pass), Past 100/100 (Pass), Health 83/100 (Pass), Moat 86/100 (Pass), Future 79/100 (Pass), Income 55/100 (Partial).
